CDK5 and Alzheimer disease: In the late Nineties Li-Huei Tsai’s lab published a paper proposing that the truncated cyclin-dependent kinase 5 (Cdk5) activator p25 is specifically formed in sporadic Alzheimer’s disease (AD; Patrick et al., 1999).